drugset / Trial / NCT02561468
The Preemptive Analgesic Efficacy of Nefopam
RandomizedParallel-groupDouble-blindPrevention
Summary
Nefopam is administered as a preemptive analgesic drug to the patient undergoing breast cancer surgery. It will be evaluated whether postoperative acute and chronic pain can be reduced.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-01
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nefopam | Small molecule | 20 mg | — |